Access the full text.
Sign up today, get DeepDyve free for 14 days.
C. Motamed, X. Mazoit, Khaldoun Ghanouchi, F. Guirimand, K. Abhay, T. Lieutaud, S. Bensaid, C. Fernandez, P. Duvaldestin (2000)
Preemptive Intravenous Morphine-6-glucuronide Is Ineffective for Postoperative Pain ReliefAnesthesiology, 92
P. Klepstad, Trude Rakvåg, S. Kaasa, M. Holthe, O. Dale, P. Borchgrevink, Cecilie Báár, T. Vikan, H. Krokan, F. Skorpen (2004)
The 118 A > G polymorphism in the human µ‐opioid receptor gene may increase morphine requirements in patients with pain caused by malignant diseaseActa Anaesthesiologica Scandinavica, 48
A. Beyer, T. Koch, H. Schröder, S. Schulz, V. Höllt (2004)
Effect of the A118G polymorphism on binding affinity, potency and agonist‐mediated endocytosis, desensitization, and resensitization of the human mu‐opioid receptorJournal of Neurochemistry, 89
E. Tan, Chay-Hoon Tan, Umavathy Karupathivan, E. Yap (2003)
Mu opioid receptor gene polymorphisms and heroin dependence in Asian populationsNeuroReport, 14
C. Szeto, N. Tang, Dominic Lee, A. Stadlin (2001)
Association between mu opioid receptor gene polymorphisms and Chinese heroin addictsNeuroreport, 12
J. Lötsch, C. Skarke, S. Grösch, J. Darimont, H. Schmidt, G. Geisslinger (2002)
The polymorphism A118G of the human mu-opioid receptor gene decreases the pupil constrictory effect of morphine-6-glucuronide but not that of morphine.Pharmacogenetics, 12 1
J. Lötsch, M. Zimmermann, J. Darimont, Claudia Marx, R. Dudziak, C. Skarke, G. Geisslinger (2002)
Does the A118G Polymorphism at the &mgr;-opioid Receptor Gene Protect against Morphine-6-Glucuronide Toxicity?Anesthesiology, 97
J. Lotsch, G. Kobal, G. Geisslinger (1998)
No Contribution of Morphine‐6-Glucuronide to Clinical Morphine Effects After Short‐Term AdministrationClinical Neuropharmacology, 21
K. Laforge, V. Shick, R. Spangler, D. Proudnikov, V. Yuferov, Y. Lysov, A. Mirzabekov, M. Kreek (2000)
Detection of single nucleotide polymorphisms of the human mu opioid receptor gene by hybridization or single nucleotide extension on custom oligonucleotide gelpad microchips: potential in studies of addiction.American journal of medical genetics, 96 5
Takeshi Hirota, I. Ieiri, H. Takane, H. Sano, K. Kawamoto, H. Aono, A. Yamasaki, H. Takeuchi, M. Masada, E. Shimizu, S. Higuchi, K. Otsubo (2003)
Sequence variability and candidate gene analysis in two cancer patients with complex clinical outcomes during morphine therapy.Drug metabolism and disposition: the biological fate of chemicals, 31 5
K. Laforge, V. Yuferov, M. Kreek (2000)
Opioid receptor and peptide gene polymorphisms: potential implications for addictions.European journal of pharmacology, 410 2-3
Road Kaohsiung City Taiwan e-mail: [email protected]
W. Pang, T. Hsu, C. Tung, C. Hung, D. Chang, M. Huang (2000)
Is total knee replacement more painful than total hip replacement?Acta anaesthesiologica Sinica, 38 3
H. Pleym, O. Spigset, E. Kharasch, O. Dale (2003)
Gender differences in drug effects: implications for anesthesiologistsActa Anaesthesiologica Scandinavica, 47
C. Skarke, J. Darimont, H. Schmidt, G. Geisslinger, J. Lötsch (2003)
Analgesic effects of morphine and morphine‐6‐glucuronide in a transcutaneous electrical pain model in healthy volunteersClinical Pharmacology & Therapeutics, 73
W. Peng, G. Wu, W. Sun, S. Fan, T. Chen, F. Huang (1992)
[Patient-controlled intravenous versus epidural analgesia after major joint replacement].Ma zui xue za zhi = Anaesthesiologica Sinica, 30 2
J. Lötsch, C. Skarke, H. Schmidt, S. Grösch, G. Geisslinger (2001)
The Transfer Half-life of Morphine-6-glucuronide from Plasma to Effect Site Assessed by Pupil Size Measurement in Healthy VolunteersAnesthesiology, 95
P. Klepstad, Stein Kaasa, P. Borchgrevink (2000)
Start of oral morphine to cancer patients: effective serum morphine concentrations and contribution from morphine-6-glucuronide to the analgesia produced by morphineEuropean Journal of Clinical Pharmacology, 55
I. Belfer, Tianxia Wu, A. Kingman, R. Krishnaraju, D. Goldman, M. Max (2004)
Candidate Gene Studies of Human Pain Mechanisms: Methods for Optimizing Choice of Polymorphisms and Sample SizeAnesthesiology, 100
L. Xin, Z. Wang (2002)
Bioinformatic analysis of the human μ opioid receptor (OPRM1) splice and polymorphic variantsAAPS PharmSci, 4
M. Holthe, P. Klepstad, K. Zahlsen, P. Borchgrevink, Lars Hagen, O. Dale, S. Kaasa, H. Krokan, F. Skorpen (2002)
Morphine glucuronide-to-morphine plasma ratios are unaffected by the UGT2B7 H268Y and UGT1A1*28 polymorphisms in cancer patients on chronic morphine therapyEuropean Journal of Clinical Pharmacology, 58
Cherie Bond, K. Laforge, M. Tian, Dorothy Melia, Shengwen Zhang, L. Borg, Jianhua Gong, J. Schluger, J. Strong, S. Leal, J. Tischfield, M. Kreek, Lei Yu (1998)
Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction.Proceedings of the National Academy of Sciences of the United States of America, 95 16
Background: Morphine consumption after a given surgical procedure can vary considerably. Studies show that single nucleotide polymorphism involving the nucleotide position 118 at exon 1 of the μ‐opioid receptor gene (OPRM1) may play a role in mediating the effects of opioids. This study was performed to correlate the A118G polymorphism at OPRM1 with morphine consumption in patients undergoing total knee arthroplasty. Methods: Post‐operative pain was relieved by patient‐controlled analgesia (PCA). The analgesic effect was evaluated using a visual analogue scale. Side‐effects, such as sedation, nausea and vomiting, and pruritus, were recorded systematically. The genotypes were determined by sequencing polymerase chain reaction‐amplified DNA. The differences in demographics and consumed morphine from the PCA device between the different genotypes were tested using one‐way analysis of variance. The prevalence of side‐effects from morphine and sex distribution were compared using the Kruskal–Wallis test. Results: One hundred and forty‐seven patients were included in the study. Twenty‐seven patients who required rescue analgesia were excluded; these patients did not differ demographically or genetically from the 120 who completed the study. Of the latter, 74 were A118 homozygous (AA), 33 were heterozygous (AG) and 13 were G118 homozygous (GG). Group GG consumed significantly more morphine (40.4 ± 22.0 mg) than group AA (25.3 ± 15.5 mg) and group AG (25.6 ± 11.7 mg) during the first 48 h post‐operatively. The groups did not differ with respect to reported pain, age, sex, weight and adverse effects. Conclusions: G118 homozygotes have a poorer response to morphine for post‐operative pain control than A118 homozygotes or heterozygotes. The genotype may thus influence the post‐operative response to pain and cause differences in the amounts of analgesic consumed by patients after total knee arthroplasty.
Acta Anaesthesiologica Scandinavica – Wiley
Published: Aug 1, 2006
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.